AGP Executive Report
Last update: 8 hours agoDiabetes Care: The FDA cleared the twiist automated insulin-delivery system for adults with insulin-treated type 2 diabetes, expanding options for a group with limited access to this technology. Rare-Disease Treatment: A European Medicines Agency committee recommended once-weekly navepegritide for children with achondroplasia; the European Commission still must decide on authorization. Career Pathways: SAS doctors at an NHS forum challenged assumptions about advancement, sharing routes into leadership, education and senior clinical roles. Health Workforce: A survey of Indians living abroad found many skilled professionals are returning, often to be closer to family; meanwhile, Texas announced $78 million for rural workforce recruitment, chronic disease prevention and facility upgrades. Medical Training: More than 93% of candidates passed the Philippines’ October physician licensing exam. Patient Safety: An inquest heard that missed blood tests delayed a baby’s meningitis diagnosis, underscoring the need to look beyond an initial diagnosis when symptoms persist.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
![<![CDATA[On the relentless rise in healthcare spending, price vs. utilization, and what employers should do about it | A conversation with Katie Martin, M.P.A.]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29485566-950218408-0d19a163f8742b8bed9b6a45357b9dc7da8f5ca1-1402x1508-186x200.png)
